Dexmedetomidine improves clinical outcomes in sepsis-induced myocardial injury: a retrospective cohort study

Dexmedetomidine improves clinical outcomes in sepsis-induced myocardial injury: a retrospective cohort study

BackgroundThe efficacy of dexmedetomidine (DEX) in treating sepsis-induced myocardial injury (SIMI) remains unclear. In this study, we explored the relationship between DEX use and clinical outcomes of patients with SIMI, focusing on the dosage and treatment duration.MethodsIn this retrospective coh...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuan Liu, Jianjie Ouyang, Cuicui Zhang, Pingping Niu, Baoling Shang, Gengzhen Yao, Yongyong Shi, Xu Zou
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Pharmacology
Subjects:
dexmedetomidine
sepsis
myocardial injury
mortality
MIMIC-IV
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1529167/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2024.1529167/full

Similar Items